Yung-Chi Cheng

Yung-Chi Cheng has been a pioneer in applying rigorous pharmacological methods to traditional Chinese medicine, leading the development and clinical evaluation of PHY906 as the first botanical drug studied under FDA IND guidelines for cancer treatment support. His decades of work establishing analytical and quality control methods for complex herbal formulas has set standards for the field of botanical drug development. He has demonstrated that traditional formulas can be studied with the same rigor as single-agent pharmaceuticals through systematic mechanistic and clinical investigation.